Amgen, the biopharmaceutical company, is opening its second-largest research and development facility in South San Francisco's Oyster Point, representing a significant pharma footprint in the Bay Area.
At nine-stories tall, the 245,000-square-foot facility will house 650 employees across 24 functions. The site also features open work spaces and modular labs, structures that are created with as many moveable furnishings as possible. These design choices are meant to encourage greater collaboration and teamwork.
Pour one out: Popular Tenderloin gastropub shuts down San Francisco outpost offered beer from"on-the-fly" taps The facility's opening was slightly delayed, as Amgen originally hoped to open their doors earlier this year. A company spokesperson said Amgen was not disclosing costs associated with the facility.